| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 443,265 | $4,432,650 | $10.00 | 21 Jun 2021 | Indirect |
| Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 370,000 | $3,700,000 | $10.00 | 21 Jun 2021 | Direct |
| Verve Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | 21 Jun 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | 21 Jun 2021 | 3 | +$7,030,000 | 4 | 10%+ Owner | 22 Jun 2021, 17:21 |
| VERV | Verve Therapeutics, Inc. | 16 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 16 Jun 2021, 19:20 |